Vasoplegia during cardiac surgery: current concepts and management

Area of Science:

• Cardiology
• Anesthesiology
• Critical Care Medicine

Background:

• Vasoplegic syndrome (VS) is a frequent complication following cardiopulmonary bypass (CPB), affecting 5-25% of patients.
• VS is defined by profound hypotension, low systemic vascular resistance (SVR), and high or normal cardiac output.
• It increases the risk of mortality and major complications in patients undergoing cardiac surgery.

Purpose of the Study:

• To review the pathophysiology of vasoplegic syndrome (VS) after cardiopulmonary bypass (CPB).
• To discuss contemporary management strategies for VS.
• To improve understanding and treatment of this critical complication.

Main Methods:

• Literature review of studies on vasoplegic syndrome (VS) and cardiopulmonary bypass (CPB).
• Analysis of pathophysiological mechanisms contributing to VS.
• Synthesis of current therapeutic approaches for VS management.

Main Results:

• VS is characterized by a hyperdynamic circulatory state with vasodilation.
• Key pathophysiological factors include inflammatory responses and nitric oxide pathway dysregulation.
• Current treatments involve fluid resuscitation, vasopressors, and inotropes, with ongoing research into novel therapies.

Conclusions:

• Vasoplegic syndrome (VS) remains a significant challenge after cardiopulmonary bypass (CPB).
• Understanding its pathophysiology is crucial for effective management.
• Prompt and appropriate treatment strategies are essential to mitigate adverse outcomes.